The U.S. Food and Drug Administration (FDA)'s warning regarding smartwatches has sparked a debate over the reliability of health features on these devices. The FDA stated that the blood sugar measurement features offered by smartwatches should not be trusted, as current technology lacks a method to directly measure the amount of glucose in the blood.
This warning is particularly important for diabetes patients, as they need to monitor their blood sugar levels regularly. However, as the FDA emphasizes, it is known that current smartwatches and similar devices cannot perform these measurements accurately.
According to the FDA's statement, smartwatches and similar devices cannot measure blood sugar, and claims that they possess such features may be misleading.
On the other hand, it is known that some companies are working in this direction. For instance, major technology firms like Apple and Samsung are conducting research on providing health data such as blood glucose measurements on their smart devices. However, it is noted that these technologies have not yet become practically usable and have not received FDA approval.
For this reason, the FDA emphasizes that smartwatches and similar devices currently on the market do not provide health data such as blood glucose measurements and advises consumers to be cautious in this regard.
News Source: 12punto
